Determination of MMP-2 and -9 activities in synovial fluid of horses with osteoarthritic and arthritic joint diseases using gelatin zymography and immunocapture activity assays.
Authors: Fietz S, Einspanier R, Hoppner S, Hertsch B, Bondzio A
Journal: Equine veterinary journal
Summary
# Editorial Summary: Matrix Metalloproteinases as Joint Disease Markers in Horses Matrix metalloproteinases (MMPs) have proven diagnostically useful in human joint disease, yet their clinical application in equine practice remains underdeveloped. Fietz and colleagues investigated whether MMP-2 and MMP-9 activity patterns in synovial fluid could differentiate between healthy joints, aseptic joint disease (AJD), and septic arthritis (SA) using gelatin zymography and immunocapture activity assays on fluid samples from affected and control joints. Both MMP-2 and MMP-9 were significantly elevated in SA compared to controls and AJD cases, whilst MMP-2 alone was significantly raised in AJD relative to healthy joints; notably, active MMP-9 and its dimer form were detected exclusively in SA samples, suggesting a distinctive inflammatory signature. As therapeutic intervention progressed in SA cases, MMP activities decreased proportionally, indicating their potential utility as objective markers of disease resolution alongside conventional clinical indicators. These findings suggest MMP profiling could strengthen diagnostic confidence in challenging joint cases and monitor treatment efficacy, though practitioners should recognise that further validation work is needed before these assays become routine aids to synovial fluid interpretation in equine orthopaedic assessment.
Read the full abstract on PubMed
Practical Takeaways
- •MMP-2 and MMP-9 activity levels in synovial fluid may help differentiate between septic and aseptic joint disease in horses, potentially supporting clinical diagnosis
- •Serial measurement of MMP activities could serve as an objective biomarker to monitor treatment response in septic arthritis cases
- •These biomarkers may supplement clinical examination and traditional diagnostic methods but require further validation before routine clinical adoption
Key Findings
- •Latent MMP-2 activity was significantly increased in both AJD and SA synovial fluid compared to control joints
- •Monomeric latent MMP-9 activity was significantly elevated in SA samples but absent in AJD and control samples
- •Immunocapture assays showed MMP-2 and MMP-9 activities were significantly higher in SA versus controls and AJD samples
- •Both MMP-2 and MMP-9 activities decreased in SA joints during successful therapy, indicating potential as disease monitoring markers